TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›MTD
MTD logo

MTD

METTLER TOLEDO INTERNATIONAL INC/

Next earnings Jul 29, 2026 (after close) · consensus $10.89 EPS, $1.04B rev

Last earnings -0.6% on 2026-05-07

Hold
$1,308.43
▲ +3.94%
$1,308.43▲ +10.46%
over 1Y
L $1,025.53H $1,506.02
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.9%
1W+5.2%
1M+11.8%
3M+3.8%
YTD-7.3%
1Y+10.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Long (>12mo)
Street · 20 analysts
Buy

Elite-margin instrument compounder firing on buybacks, but full price and China/end-market headwinds cap near-term upside.

Revenue $4.03B · FY2025

The read

Middling fundamentals and a rich price (~59% above fair value) leave little margin of safety — a wait-and-see.

Mettler-Toledo is a textbook quality business: 59.4% gross margin, 21.6% net margin, and $956M of operating cash flow on $4.03B of revenue. Net income has compounded steadily but slowly — from $769M (FY2021) to $869M (FY2025), with FY2025 net income up just 0.7% and revenue up 4.0%. Management spent $800M on buybacks in FY2025, shrinking the share count 2.8%, which is why diluted EPS ($42.05) grew 3.9% — faster than net income. This is a cash-generative compounder, not a fast grower.

The scary-looking balance sheet is an artifact, not distress. Stockholders' equity is -$23.6M and ROE prints -3677%, but that is the mechanical result of years of buybacks ($800M in FY2025 alone) drawing equity down even as retained earnings sit at $9.24B. With long-term debt of $2.09B against $956M annual operating cash flow and only $66.9M cash, leverage is real but comfortably serviceable for a business this profitable; the negative book value should not be read as solvency risk. Current assets ($1.36B) exceed current liabilities ($1.20B).

Is MTD a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~1308.43
  • Short call 1370 @ ~68.00 est
debit $124,043max +$12,957max −$124,042BE 1240.43

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$3.72B$3.92B$3.79B$3.87B$4.03B
Gross profit$2.17B$2.31B$2.24B$2.33B$2.39B
Operating income—————
Net income$769M$873M$789M$863M$869M
Diluted EPS$32.78$38.41$35.90$40.48$42.05
Net margin20.7%22.3%20.8%22.3%21.6%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$28.5B
EV / EBITDA—
EV / Sales7.1
EV / FCF33.6
P / FCF31.2
PEG (trailing)44.37
Earnings yield3.3%
FCF yield3.2%

Quality & risk

ROIC (est.)—
Free cash flow$849M
Total debt$2.15B
Net cash-$2.09B
Piotroski F-Score6/9

Capital returns

Buyback yield3.0%
Dividend yield (est.)—
Shareholder yield3.0%
Shares Δ YoY-2.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-05-13
  2. 8-K Shareholder vote2026-05-11
  3. 10-Q Quarterly report2026-05-08
  4. 8-K Earnings results2026-05-07
  5. DEF 14A Proxy statement2026-03-18
  6. 10-K Annual report2026-02-06
  7. 8-K Earnings results2026-02-05
  8. 8-K Officer / director change2026-01-20
  9. 10-Q Quarterly report2025-11-07

Recent filings

all on EDGAR ↗
11-KPeriod ending 2025-12-312026-06-26open ↗SDFiling2026-05-29open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗4Period ending 2026-05-122026-05-14open ↗8-KPeriod ending 2026-05-072026-05-13open ↗8-KPeriod ending 2026-05-072026-05-11open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-05-072026-05-07open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC-
GrowthC
ProfitabilityA
Financial healthF
MomentumB-
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$530.24

Overvalued -59% vs price

cheapfair valueexpensive

Modified Graham: EPS $42.05 × (8.5 + 1.5 × 2.3% growth) × 1.05 quality = 12.6× multiple. An estimate, not a price target.

1025.5352-week1506.02
Revenue
$4.03B
+4.0% YoY
Net margin
21.6%
ROE
—
P/E
31.1

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$4.03B+4.0%
Net income$869M+0.7%
Gross profit$2.39B+2.8%
Diluted EPS$42.05+3.9%
Cash & equivalents$66.9M+12.7%
Total assets$3.71B+14.6%
Total liabilities$3.74B+11.0%
Stockholders' equity-$23.6M+81.4%
Gross: 59.4%L/E: -158.08x

Frequently asked

Is METTLER TOLEDO INTERNATIONAL INC/ (MTD) a buy?
MTD currently carries a Hold rating with 4/5 conviction, derived from its latest SEC filings. Elite-margin instrument compounder firing on buybacks, but full price and China/end-market headwinds cap near-term upside.
What is MTD's fair value?
A Modified-Graham model based on MTD's SEC fundamentals estimates a fair value of about $530.24. It is an estimate from reported earnings, not a price target.
Is MTD overvalued or undervalued?
Against a Modified-Graham fair-value estimate, MTD currently appears overvalued relative to its SEC-grounded earnings power.
What is METTLER TOLEDO INTERNATIONAL INC/'s quality score?
MTD scores 60.25661338155307/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001037646, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/21/2026, 7:08:51 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 3:08 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-12
Wong Ann Ping Richard
Head of Asia & Pacific
Award103.00
2026-05-12
Wittorf Oliver
Head of PI, Retail, and GSC
Award87.00
2026-05-12
Vadala Shawn
Chief Financial Officer
Award291.00
2026-05-12
Keller Gerry
Head of Process Analytics
Award100.00
2026-05-12
Kaltenbach Patrick
President and CEO
Award810.00
2026-05-12
Graham-Bryce Susan
Chief Human Resources Officer
Award71.00
2026-02-17
TOKICH MICHAEL J
Director
Award50.00
2026-02-10
Vadala Shawn
Chief Financial Officer
Exercise800.00 @ $595.31$476K
2026-02-10
Vadala Shawn
Chief Financial Officer
Sell800.00 @ $1,410.12$1.13M

Held by tracked funds

Form 13F · SEC · quarterly
D. E. Shaw & Co.73.1K sh$92.2M
Bridgewater AssociatesRay Dalio (founder)5.14K sh$6.48M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Earnings history

beat/miss · move
2026-05-07Beat +1.4% est▼ -14.44%8-K ↗
2026-02-05Beat +3.3% est▼ -0.71%8-K ↗
2025-11-06Beat +3.8% est▲ +1.63%8-K ↗
2025-08-01Beat +4.0% est▲ +0.27%8-K ↗
2025-05-01—▲ +2.80%8-K ↗
2024-11-07—▲ +9.27%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

2 buys · 1 sell · 1 member · last 180d

+$8.00K net boughtlast trade 209d ago
$16.0K bought$8.00K sold
2026-01-13Julia LetlowBuy$1.00K–$15.0KPTR ↗
2026-01-13Julia LetlowBuy$1.00K–$15.0KPTR ↗
2026-01-13Julia LetlowSell$1.00K–$15.0KPTR ↗
2025-05-31Rob BresnahanBuy$1.00K–$15.0KPTR ↗
2025-05-14Julie JohnsonSell$1.00K–$15.0KPTR ↗
2025-04-28Rob BresnahanSell$1.00K–$15.0KPTR ↗
2018-11-07Gary PalmerSell$1.00K–$15.0KPTR ↗
2018-09-29Gary PalmerBuy$1.00K–$15.0KPTR ↗
2018-09-29Gary PalmerBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Q1 Earnings Roundup: Mettler-Toledo (NYSE:MTD) And The Rest Of The Research Tools & Consumables SegmentBullish
finance.yahoo.com· 2026-07-03
3 Reasons to Sell MTD and 1 Stock to Buy InsteadBullish
finance.yahoo.com· 2026-07-01
Are Options Traders Betting on a Big Move in Mettler-Toledo Stock?Bullish
finance.yahoo.com· 2026-06-29
Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last?Bullish
finance.yahoo.com· 2026-06-29
Mettler-Toledo (MTD) Soars 3.3%: Is Further Upside Left in the Stock?Bullish
finance.yahoo.com· 2026-06-26
3 Profitable Stocks We Keep Off Our RadarBullish
finance.yahoo.com· 2026-06-26

Vs Health Care peers

compare →

148 tracked peers · median

TENK Score60 vs 64
Revenue growth4.0% vs 9.8%
Net margin21.6% vs 7.3%
Return on equity— vs 9.9%
P/E31.1 vs 30.3
Peers
INCYEXELTGTXJNJSOLVUTHRAMGNMRK